Add BrightSurf on Google Email

Johns Hopkins Medicine


Treatment provides dramatic survival benefit for hard-to-match kidney transplant patients

A new treatment protocol has been shown to dramatically increase the survival rate of patients with incompatible kidneys, doubling their chances of eight-year survival. The treatment involves removing problematic antibodies from a patient's blood prior to transplant and aims to replace them with low-dose IVIg, resulting in an 80.6% sur...

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateJul 27, 2011

Combination therapy as good as old regimen to prevent full-blown TB in people with/without HIV

A new combination therapy of rifapentine and isoniazid, taken once weekly for three months, has been shown to be as effective as traditional daily treatment in preventing latent tuberculosis in people with and without HIV. The study found that 95% of participants completed the treatment, compared to 60% or less with traditional therapy.

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateJul 6, 2011

Just add water and treat brain cancer

Researchers have developed a novel gene therapy system using nanoparticles that can be freeze-dried and stored for up to three months. The technology shows promise in treating brain cancer with high efficacy and minimal risk of complications, offering a potential alternative to traditional therapies.

SourceJohns Hopkins Medicine·JournalBiomaterials·DateJul 5, 2011

How muscle develops: A dance of cellular skeletons

Muscle cell fusion is crucial for understanding normal muscle growth and regeneration after injury or disease. Johns Hopkins researchers discovered the role of a regulatory protein called Blown Fuse in facilitating muscle cell merging by disrupting the WASP-WIP protein duo, which regulates cytoskeleton dynamics.

SourceJohns Hopkins Medicine·JournalDevelopmental Cell·DateJun 3, 2011

New genetic testing technology for IVF embryos

Researchers at Johns Hopkins University have developed a new technique to detect both genetic diseases and chromosomal abnormalities in IVF embryos. This method allows for the simultaneous detection of single-gene mutations and aneuploidy, enabling couples to choose healthy embryos for implantation.

SourceJohns Hopkins Medicine·JournalFertility and Sterility·DateMay 23, 2011

What doesn't kill the brain makes it stronger

A Johns Hopkins team has identified a newly discovered protein called Iduna that protects the brain against stroke and neurologic disorders. The protein works by interrupting a cascade of molecular events that result in cell death, and its presence increases three- to four-fold in preconditioned mouse brain tissue.

SourceJohns Hopkins Medicine·JournalNature Medicine·DateMay 23, 2011

Gene variation linked to infertility in women, study finds

A study from Johns Hopkins researchers found a link between a gene variation and infertility in women, with the altered gene affecting cholesterol regulation and pregnancy hormone production. The discovery may lead to a treatment for this condition, as a cholesterol medication shown to work in mice could potentially restore fertility.

SourceJohns Hopkins Medicine·JournalHuman Reproduction·DateMay 16, 2011

Blood pressure drug shows some muscle

Researchers discovered losartan improves muscle regeneration and prevents wasting away from inactivity in geriatric mice. The study suggests losartan may have broader clinical applications in protecting against immobilization atrophy in older adults.

SourceJohns Hopkins Medicine·JournalScience Translational Medicine·DateMay 11, 2011

Adult stem cells take root in livers and repair damage

Researchers at Johns Hopkins Medicine have successfully coaxed adult human cells into an embryonic state and used them to regenerate liver tissue in mice with chronic liver damage. The induced-pluripotent stem cells (iPSCs) showed promise as a potential alternative to liver transplants for patients with serious liver diseases, offering...

SourceJohns Hopkins Medicine·JournalScience Translational Medicine·DateMay 11, 2011

Animal studies reveal new route to treating heart disease

Researchers found that blocking the action of a signaling protein in cardiac muscle cells halted serious ill effects of high blood pressure on the heart, including enlargement and scar tissue formation. Further tests revealed potential new treatments for heart failure by targeting specific proteins involved in disease progression.

SourceJohns Hopkins Medicine·JournalJournal of Clinical Investigation·DateMay 2, 2011